GSK

Jemperli

ASP | WAC | AWP at the HCPCS Unit

Manufacturer:

GSK

Jemperli HCPCS:

J9272

HCPCS Code Descriptor:

Injection, dostarlimab-gxly, 10 mg

Category:

J Code

Jemperli NDCs:

00173-0898-03

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Jemperli CPT Codes:

Potential CPT administration codes for Jemperli can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Jemperli:

Jemperli is an Oncology drug manufactured by GSK and administered via the Intravenous route of administration. The J Code: J9272 is aligned to the drug Jemperli.

ACCESS PRICING AND MORE BY REGISTERING

J9272 Added Date:

January 1, 2022

J9272 Effective Date:

January 1, 2022

J9272 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Jemperli billing and coding information.
Jemperli patient assistance information can be found through GSK Oncology at the URL: https://jemperli.com/support-resources/
Jemperli prescribing information can be found at the link below:
Information regarding Jemperli’s side effects can be found at MedlinePlus